← Back to JNJ

JNJ Free Cash Flow

Cash generated after capital expenditures.

JNJ Free Cash Flow
2025Q3$8.1B
*Quarterly, USD

Healthcare Comparison

Healthcare, pharmaceuticals, and medical technology

1 / 5
UNH Free Cash Flow
0
2025Q4$160.0M
*vs JNJ
ABBV Free Cash Flow
0
2025Q3$6.6B
*vs JNJ
LLY Free Cash Flow
0
2025Q4$6.7B
*vs JNJ
HIMS Free Cash Flow
0
2025Q3$83.5M
*vs JNJ
LMND Free Cash Flow
0
2025Q3$2.6M
*vs JNJ

Other JNJ Charts

1 / 4
Revenue
2025Q4$24.6B
*Quarterly revenue growth, USD
EPS
0
2025Q4$2.10
*Earnings per share, USD per share
Cumulative FCF
2025Q3$274.0B
*Running FCF total, USD
P/E Ratio
2025Q418.73
*Price-to-earnings, x
Learn more about Free Cash Flow →